| abstract |
The present invention relates to (+)-1- (3,4-dichlorophenyl) -3-azabicyclo [3.1.0] hexane and pharmaceutically acceptable salts thereof, (+)-1- (3,4-dichlorophenyl) -3-Azabicyclo [3.1.0] hexane or a pharmaceutically acceptable salt thereof, and (+)-1- (3,4-dichlorophenyl) -3-azabicyclo [3.1.0] hexane Or a method of treating or preventing relapse of a patient's depression, anxiety disorder, eating disorder, or urinary incontinence, comprising administering a pharmaceutically acceptable salt thereof. (+)-1- (3,4-Dichlorophenyl) -3-azabicyclo [3.1.0] hexane or a pharmaceutically acceptable salt thereof is preferably substantially free of its corresponding (−)-enantiomer. . |